News Releases Year: - Any -2021202020192018201720162015201420132012 Items per page 102550 01/10/13 Summary ToggleClearside Biomedical Announces Plans for Clinical Testing of CLS1001 (Triamcinolone Acetonide) Suprachoroidal Injectable Suspension for the Treatment of Uveitis Releasef0757699-d36f-43fe-9338-7a74457ccfb3_1981140.pdf 9.2 KB 11/06/12 Summary ToggleClearside Biomedical Announces First Successful Human Dosing – November 6, 2012 Releaseb72f6291-3086-4e62-93c3-2ccf0414eadd_1981141.pdf 13.7 KB 10/29/12 Summary ToggleClearside Biomedical Names Charles Deignan Chief Financial Officer Releaseff0901e3-c4ae-4ae6-aa9c-1d3a839ea42c_1981143.pdf 9.1 KB 01/25/12 Summary ToggleClearside Biomedical Launched with Pipeline and Technology Focused on Drugs Delivered to the Back of the Eye Release4e0e3fd0-1d7d-4dc4-8bcf-7d1d0f280237_1981144.pdf 17.1 KB Pagination First page First Previous page Page 16 Page 17 Page 18 Current page 19
